SMC approves bulevirtide for treatment of chronic HDV infection in Scottish patients
Gilead Sciences has announced that the Scottish Medicines Consortium (SMC) has become the first UK health authority to permit routine NHS use of Hepcludex...
Engage with Experts: Connect with industry leaders, renowned pharmacists, and forward-thinking researchers through exclusive live Q&A sessions and engaging discussions. Tap into their wisdom, ask burning questions, and gain invaluable insights to fuel your passion for pharmacy
Copyright © 2023 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc